BNP Paribas Financial Markets
ACHV icon

BNP Paribas Financial Markets’s Achieve Life Sciences ACHV Stock Holding History

BNP Paribas Financial Markets’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$792K Buy
121,215
+120,961
+47,622% +$577K ﹤0.01% 3476
2026
Q1 		$747 Sell
254
-167,691
-100% -$745K ﹤0.01% 5501
2025
Q4 		$835K Buy
167,945
+167,635
+54,076% +$731K ﹤0.01% 3237
2025
Q3 		$977 Sell
310
-460
-60% -$1.26K ﹤0.01% 5239
2025
Q2 		$1.74K Sell
770
-1,298
-63% -$3.7K ﹤0.01% 5077
2025
Q1 		$5.52K Sell
2,068
-2,807
-58% -$8.73K ﹤0.01% 4841
2024
Q4 		$17.2K Buy
+4,875
New +$22.1K ﹤0.01% 4751
2022
Q4 		– Sell
-100
Closed -$330 – 4029
2022
Q3 		$330 Buy
+100
New +$477 ﹤0.01% 4560
2014
Q2 		– Hold
0
– -$283 – 3818
2014
Q1 		– Hold
0
– – – 3157
2013
Q4 		– Hold
0
– – – 3679

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BNP Paribas Financial Markets's ACHV Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Achieve Life Sciences (ACHV) stake by 47,622% in Q2 2026, buying an estimated $577K and bringing the position to 121,215 shares worth $792K. The position accounts for ﹤0.01% of the portfolio, ranked #3476.

BNP Paribas Financial Markets first reported a position in ACHV in Q3 2022 and has held it in 8 quarters since. The position peaked at $835K in Q4 2025. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • BNP Paribas Financial Markets held 121,215 shares of Achieve Life Sciences worth $792K as of Q2 2026.
  • BNP Paribas Financial Markets bought 120,961 Achieve Life Sciences shares in Q2 2026, an estimated $577K.
  • Achieve Life Sciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3476 holding.
  • BNP Paribas Financial Markets first reported a position in Achieve Life Sciences in Q3 2022 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's Achieve Life Sciences position peaked at $835K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.